Catheter Precision, Inc. (VTAK) Stock Price

VTAKStock
$0.2193.09%52W
Market Cap$758,349.857
P/E
PEG Ratio
Div yield
Beta-1.08

VTAK Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-98.96%
Price vs S&P 500 (4W)-28.48%
VGM Score55.63

VTAK Earnings Surprise History

Q1 24-68.40est. -7.98
Q2 24-105.83est. -4.94
Q3 24-38.19est.

VTAK Analyst Recommendations

Jun 2025
Jul 2025
Aug 2025
Oct 2025
4.29
4.29
4.29
4.29

Industry Peers — Surgical & Medical Instruments(140)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
VTAKCatheter Precision, Inc.
BAF$0.21
SYKStryker CorporationCBC$330.59
MMM3M CompanyCDB$179.37
BSXBoston Scientific Corp.CBD$49.86
BDXBecton, Dickinson and Co.BDB$189.78
MDLNMedline Inc. Class A common stockCDC$35.64
RMDResMed Inc.CBC$236.59
DXCMDexCom, Inc.DBB$89.16
WSTWest Pharmaceutical Services, Inc.DCB$348.48
SOLVSolventum CorporationCCB$91.61
BAXBaxter International Inc.BDB$26.29

About Catheter Precision, Inc.

Cathay Precision Inc is a medical device company specializing in cardiac electrophysiology solutions. Its lead product, the VIVO System, is a non-invasive 3D cardiac mapping platform for identifying ventricular arrhythmia origins prior to EP procedures and holds CE Mark approval for European commercialization. The company is expanding its product portfolio with LockeT, a surgical suture retention device designed to improve wound healing outcomes.